The Puget Sound Business Journal published news that Seattle Genetics, a biotechnology company focused on enhancing the survival of cancer patients, has just made a deal with a wholly-owned subsidiary of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company. Read the article here.
No comments:
Post a Comment